A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways

Title
A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 7, Pages 1637-1649
Publisher
American Association for Cancer Research (AACR)
Online
2015-05-07
DOI
10.1158/1535-7163.mct-14-1040

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started